Phase III randomized clinical trial comparing the effects of autologous bone marrow derived MNC and CD133 cells transplantation in ami patients during CABG

✍ Scribed by Nasseri, M.H.; Aghdami, N.; Ahmadi, H.; Moshkani Farahani, M.; Madani, H.; Kazemi-Saleh, D.; Hossein-neghad, H.; Hosseini, S.; Hekmat, S.; Ahmadi, Z.; Dehghani, M.; Saadat, A.; Mardpour, S.; Hosseini, E.S.; Esmaeelzadeh, M.; Sadeghi, M.; Bahoosh, G.; Bassi, A.; Amin, A.; Fazeli, R.; Sharafi, Y.; Arab, L.; Movahed, M.; Ramazanzadeh, N.; Kohkan, A.; Hezavee, A.; Namiri, M.; Kashfi, F.; Akhlaghi, A.; Baharvand, H.; Vosough, A.; Gourabi, H.; Shahverdi, A.

• Book ID: 122793121
• Publisher: Informa plc
• Year: 2013
• Tongue: English
• Weight: 43 KB
• Volume: 15
• Category: Article
• ISSN: 1465-3249
• DOI: 10.1016/j.jcyt.2013.01.044